|
Volumn 18, Issue 6, 1993, Pages 1300-1305
|
Long‐term follow‐up of patients with chronic hepatitis C treated with different doses of interferon‐α2b
a a a b b b b c c c c d d d d d a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ALANINE AMINOTRANSFERASE;
HEPATITIS C ANTIBODY;
RECOMBINANT ALPHA2B INTERFERON;
ADULT;
AGED;
ALANINE AMINOTRANSFERASE BLOOD LEVEL;
ANTIBODY RESPONSE;
ARTICLE;
CHRONIC HEPATITIS;
CONTROLLED STUDY;
DOSE RESPONSE;
ENZYME LINKED IMMUNOSORBENT ASSAY;
FEMALE;
FOLLOW UP;
HEPATITIS C;
HEPATITIS NON A NON B;
HISTOPATHOLOGY;
HUMAN;
HUMAN TISSUE;
IMMUNOTHERAPY;
LIVER BIOPSY;
LIVER CIRRHOSIS;
MAJOR CLINICAL STUDY;
MALE;
PRIORITY JOURNAL;
SCORING SYSTEM;
SUBCUTANEOUS DRUG ADMINISTRATION;
VIRUS HEPATITIS;
ADULT;
ANTIGENS, VIRAL;
CHRONIC DISEASE;
FEMALE;
FOLLOW-UP STUDIES;
HEPACIVIRUS;
HEPATITIS ANTIBODIES;
HEPATITIS C;
HEPATITIS C ANTIBODIES;
HEPATITIS C ANTIGENS;
HUMAN;
INTERFERON ALFA-2B;
MALE;
MIDDLE AGE;
PROGNOSIS;
RNA, VIRAL;
|
EID: 0027438330
PISSN: 02709139
EISSN: 15273350
Source Type: Journal
DOI: 10.1002/hep.1840180603 Document Type: Article |
Times cited : (214)
|
References (16)
|